title: Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.
authors.forename: Michael X
authors.initials: MX
authors.lastname: Repka
authors.forename: Raymond T
authors.initials: RT
authors.lastname: Kraker
authors.forename: Roy W
authors.initials: RW
authors.lastname: Beck
authors.forename: C Scott
authors.initials: CS
authors.lastname: Atkinson
authors.forename: Darron A
authors.initials: DA
authors.lastname: Bacal
authors.forename: Don L
authors.initials: DL
authors.lastname: Bremer
authors.forename: Patricia L
authors.initials: PL
authors.lastname: Davis
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Gearinger
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Glaser
authors.forename: Darren L
authors.initials: DL
authors.lastname: Hoover
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Laby
authors.forename: David G
authors.initials: DG
authors.lastname: Morrison
authors.forename: David L
authors.initials: DL
authors.lastname: Rogers
authors.forename: Nicholas A
authors.initials: NA
authors.lastname: Sala
authors.forename: Donny W
authors.initials: DW
authors.lastname: Suh
authors.forename: Maynard B
authors.initials: MB
authors.lastname: Wheeler
mesh_terms: D000293:Adolescent; D000550:Amblyopia / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D015259:Dopamine Agents / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage*; D008297:Male; D010865:Pilot Projects; D011446:Prospective Studies; D014792:Visual Acuity / Q000502:physiology
chemical_list: D015259:Dopamine Agents; D007980:Levodopa